CALLIGARI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.705
AS - Asia 843
EU - Europa 473
SA - Sud America 112
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.162
Nazione #
US - Stati Uniti d'America 1.685
SG - Singapore 376
IT - Italia 199
VN - Vietnam 126
CN - Cina 121
HK - Hong Kong 117
RU - Federazione Russa 98
BR - Brasile 93
IE - Irlanda 37
JP - Giappone 34
GB - Regno Unito 30
DE - Germania 26
FI - Finlandia 17
IN - India 16
FR - Francia 15
CA - Canada 11
PL - Polonia 9
BD - Bangladesh 8
ID - Indonesia 8
KR - Corea 8
MA - Marocco 8
NL - Olanda 7
AT - Austria 5
ES - Italia 5
MX - Messico 5
ZA - Sudafrica 5
AR - Argentina 4
PH - Filippine 4
PY - Paraguay 4
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
IQ - Iraq 3
MY - Malesia 3
SA - Arabia Saudita 3
SE - Svezia 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DZ - Algeria 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
NO - Norvegia 2
RO - Romania 2
TN - Tunisia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.162
Città #
Wilmington 387
Houston 328
Singapore 247
Hong Kong 114
San Jose 114
Ashburn 103
Fairfield 95
Rome 92
Beijing 54
Woodbridge 41
Cambridge 40
Ho Chi Minh City 39
Seattle 39
Council Bluffs 34
Tokyo 33
Hanoi 32
Dublin 31
Santa Clara 31
Los Angeles 29
Medford 24
Creede 22
New York 16
Dallas 15
Moscow 14
Ann Arbor 13
Lappeenranta 13
Nuremberg 13
The Dalles 12
Lawrence 11
São Paulo 11
Dearborn 10
Lauterbourg 10
London 10
Buffalo 9
Orem 9
Redondo Beach 9
Seoul 8
San Diego 7
Warsaw 7
Biên Hòa 6
Chandler 6
Da Nang 6
City of London 5
Colorado Springs 5
Denver 5
Guangzhou 5
Hải Dương 5
Menlo Park 5
Milan 5
North Bergen 5
Atlanta 4
Bologna 4
Brooklyn 4
Bắc Ninh 4
Chicago 4
Frankfurt am Main 4
Haiphong 4
Johannesburg 4
Le Polo 4
Mountain View 4
Porto Alegre 4
Salvador 4
Segni 4
Shanghai 4
Viterbo 4
Belo Horizonte 3
Can Tho 3
Caraguatatuba 3
Casablanca 3
Engelhard 3
Helsinki 3
Hyderabad 3
Las Vegas 3
Phoenix 3
Pune 3
Redwood City 3
Reggio Emilia 3
San Francisco 3
Tashkent 3
Toronto 3
Vienna 3
Washington 3
Zurich 3
Augusta 2
Bari 2
Basingstoke 2
Bracciano 2
Cairo 2
Casorate Primo 2
Chennai 2
Del Norte 2
Florence 2
Fortaleza 2
Guaíba 2
Hangzhou 2
Jakarta 2
Jeddah 2
Kuala Lumpur 2
Manaus 2
Manila 2
Totale 2.332
Nome #
Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome 292
Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors 256
Nano-bio interactions: a neutrophil-centric view 237
Pathogenic PTPN11 variants involving the poly-glutamine Gln255-Gln256-Gln257 stretch highlight the relevance of helix B in SHP2's functional regulation 234
Design, synthesis, antibacterial potential, and structural characterization of N-acylated derivatives of the human autophagy 16 polypeptide 228
Molecular investigation of SARS-CoV-2 proteins and their interactions with antiviral drugs 184
Gating-affecting mutations in KCNK4 cause a recognizable neurodevelopmental syndrome 169
A Recurrent gain-of-function mutation in CLCN6, encoding the ClC-6 Cl−/H+-exchanger, causes early-onset neurodegeneration 151
Structural determinants of phosphopeptide binding to the N-terminal Src homology 2 domain of the SHP2 phosphatase 123
Molecular and cellular evidence of a direct interaction between the TRAF2 C-terminal domain and ganglioside GM1 106
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state 106
Computational Evaluation of Peptide–Protein Binding Affinities: Application of Potential of Mean Force Calculations to SH2 Domains 90
Targeting oncogenic Src homology 2 domain-containing phosphatase 2 (SHP2) by inhibiting its protein-protein interactions 88
Isoamphipathic antibacterial molecules regulating activity and toxicity through positional isomerism 87
Fluorescent Labeling Can Significantly Perturb Measured Binding Affinity and Selectivity of Peptide-Protein Interactions 85
Investigation of the Mechanism of Action of Natural and Synthetic Monoterpenoids: For a New Route in Antimycotic Molecules 82
Fluorescence Anisotropy and Polarization in the Characterization of Biomolecular Association Processes and Their Application to Study SH2 Domain Binding Affinity 77
Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome 71
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches 69
Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function 66
Mechanistic Insights into the Membrane Permeabilization Activity of Antimicrobial Prenylated Isoflavonoids: A Comparative Study of Glabridin, Wighteone, and Lupiwighteone 65
Modelling of Ca 2+ -promoted structural effects in wild type and post-translationally modified Connexin26 62
Insights into internal dynamics of 6-phosphogluconolactonase from Trypanosoma brucei studied by nuclear magnetic resonance and molecular dynamics 51
nMoldyn - Interfacing spectroscopic experiments, molecular dynamics simulations and models for time correlation functions 49
Adaptation of Extremophilic Proteins with Temperature and Pressure: Evidence from Initiation Factor 6 43
Decomposition of Proteins into Dynamic Units from Atomic Cross-Correlation Functions 39
Integrated Computational Approach to the Electron Paramagnetic Resonance Characterization of Rigid 3(10)-Helical Peptides with TOAC Nitroxide Spin Labels 38
Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor 32
Effects of peptide labeling on fluorescence binding assays to Src homology 2 domains: the case of protein-protein interactions inhibitors of the oncogenic phosphatase SHP2 32
Decoding C-SH2 Domain/Peptide Interactions in SH2 Domain-Containing Tyrosine Phosphatase 2: A Molecular Framework for Rational Inhibitor Design 31
Multiple scale dynamics in proteins probed at multiple time scales through fluctuations of NMR chemical shifts 28
Peptide inhibitors of proteinprotein interactions targeted to SRC homology 2 domains: a combined computational and spectroscopic design approach 28
Totale 3.299
Categoria #
all - tutte 11.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 10 5
2021/2022167 14 16 8 4 6 1 23 11 13 17 25 29
2022/2023148 17 1 1 3 2 28 13 4 61 0 15 3
2023/2024124 6 1 12 8 20 10 12 2 7 25 2 19
2024/2025531 11 49 25 29 5 78 89 39 35 55 78 38
2025/20261.305 137 86 115 93 125 48 247 164 146 136 8 0
Totale 3.299